News: Get insight into the next EU Framework Programme 26 January 2012; New market research report on Nanotechnology in Medical Applications 26 January 2012; Call for Papers and Posters for the European Summit for Clinical Nanomedicine 2012 11 January 2012; NANOFAR: New European Doctorate in Nanomedicine and Pharmaceutical Innovation 25 October 2011; Catalan Strategic Agenda of Nanobiotechnology published 25 October 2011

Nanomed News: Arrowhead Reports Fiscal 2012 First Quarter Financial Results - EON: Enhanced Online News (press release) 10 February 2012; Nano Medicine Takes a Leap Forward (NNVC, ARWR, RNN) - SmallCap Network 01 February 2012; Nanomedicine : "Russian doll" polymer vesicles mimic cell structure - HealthCanal.com 30 January 2012; UAMS Begins Nanomedicine Study Center - Fort Smith Times Record 24 January 2012; More…

Upcoming Events: NanoImpactNet – QNano conference Dublin, Ireland,
27 February 2012; Biological Barriers 2012 Saarland University, Germany,
29 February 2012; Tissue Regeneration Strategies and Innovative Biomaterials in Orthopaedic Surgery Brighton, UK,
03 April 2012; Innovation in Healthcare without borders Brussels, Belgium,
16 April 2012; Spring Conference “Nanomedicine: Visions, Risks, Potential” Berlin, Germany,
19 April 2012; Upcoming events…

Mike Eaton on "Healthcare Translatability"

— filed under: News, Featured Internal

Presentation at the EuroNanoMed workshop in Iceland: "What does Healthcare Translatability mean for Nanomedicine– and whose view counts?"

Translatability

Peer Review is only part of the process and will not help stakeholders, unless applied research is translatable and of global originality.

Mike Eaton gave a presentation addressing amongst other the following topics:

- Reasons for academic healthcare research funding?

- Changes in corporate organisations

- Outsourcing & Open Innovation

- Specificities of Nanopharmaceuticals?

- How to create impact.

- Translatability

- Evaluation

Mike Eaton on "Healthcare Translatability "